Hematologic malignancies including leukemia are forms of cancer that begin in the immature white cells of blood-forming tissues including bone marrow and the immune system. Researchers at the Center for Childhood Cancer Research are using state-of-the art genomic, immunotherapeutic and targeted molecular approaches to develop new therapies to treat pediatric leukemias and related hematologic malignancies.